Skip to main content

Sexually Transmitted Infections

0
Pipeline Programs
2
Companies
3
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Human BioSciences
Human BioSciencesWV - Martinsburg
2 programs
IMARAN/A1 trial
Parental Knowledge and Attitudes of Confidential Sexually Transmitted Infections (STI) Services for N/A1 trial
Active Trials
NCT04758390Completed1,290Est. Oct 2024
NCT01144871Completed1,216Est. Aug 2011
Angeles Therapeutics
Angeles TherapeuticsCA - Los Angeles
1 program
ExperimentalN/A1 trial
Active Trials
NCT01198418Completed181Est. Nov 2017

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Human BioSciencesIMARA
Angeles TherapeuticsExperimental
Human BioSciencesParental Knowledge and Attitudes of Confidential Sexually Transmitted Infections (STI) Services for

Clinical Trials (3)

Total enrollment: 2,687 patients across 3 trials

A Comprehensive HIV Prevention Package for South African Adolescent Girls and Young Women

Start: Oct 2021Est. completion: Oct 20241,290 patients
N/ACompleted

A Web-based Intervention Study to Reduce High-risk Sexual Behavior by Persons Living With HIV AIDS (PLWH)

Start: Jul 2010Est. completion: Nov 2017181 patients
N/ACompleted
NCT01144871Human BioSciencesParental Knowledge and Attitudes of Confidential Sexually Transmitted Infections (STI) Services for

Parental Knowledge and Attitudes of Confidential Sexually Transmitted Infections (STI) Services for Teens

Start: Sep 2007Est. completion: Aug 20111,216 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.